Head of Translational Medicine & Early Development

Flagship Pioneering, Inc.; Cambridge (MA); Presencial; USD 350 000 - 700 000; Tempo integral

Resumo da oferta

Quotient Therapeutics seeks a senior clinical leader to serve as Vice President of Translational Medicine, integrating clinical insights across discovery, translational biology and development to prioritize disease areas, targets, and early clinical strategies with a high probability of success.

The VP will lead cross-functional teams, oversee Phase 1/2 programs with CROs, and contribute to regulatory strategy while advancing novel targets from somatic genomics. MD or MD/PhD preferred.

Qualificações

• Senior clinical leadership experience in early-stage biotech or pharma.
• Proven ability to translate scientific ideas into clinical development strategies.
• Ability to integrate inputs across scientific, clinical, regulatory and commercial functions.
• Strong strategic aptitude for prioritizing disease areas and assets.

Responsabilidades

• Provide expert clinical insight into disease area strategy and translational planning.
• Oversee early target medicine profile development across discovery projects.
• Lead cross-functional collaboration with CROs and internal teams for Phase 1/2 programs.
• Contribute to regulatory submissions and external storytelling with investors and partners.
• Adopt AI-driven tools to support indication ideation and trial prediction.

Conhecimentos

Clinical leadership

Translational medicine

MD/PhD

Strategic planning

Formação académica

MD/MD-PhD

Ferramentas

AI algorithms

Descrição da oferta de emprego

Quotient Therapeutics seeks a senior clinical leader to serve as Vice President of Translational Medicine, integrating clinical insights across discovery, translational biology and development to prioritize disease areas, targets, and early clinical strategies with a high probability of success.

The VP will lead cross-functional teams, oversee Phase 1/2 programs with CROs, and contribute to regulatory strategy while advancing novel targets from somatic genomics. MD or MD/PhD preferred.